SMARCB1 and brain neoplasm: Collectively, our findings from both the primary brain tumor cohort and the I2A cell line suggest that the SMARCB1 deficiency may prime ATRTs for the induction of viral mimicry, a response that can be further enhanced upon EZH2 inhibition.